These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6098233)

  • 1. [Effect of renal insufficiency on the pharmacokinetics of captopril and converting enzyme inhibition in the hypertensive patient].
    Richer C; Chaignon M; Giroux B; Guédon J; Giudicelli JF
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1216-9. PubMed ID: 6098233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients.
    Giudicelli JF; Chaignon M; Richer C; Giroux B; Guedon J
    Br J Clin Pharmacol; 1984 Nov; 18(5):749-58. PubMed ID: 6095887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood concentration and urinary excretion of captopril (SQ 14,255), angiotensin converting enzyme activity and R-A-A system after administration of captopril--in patients with chronic renal failure compared with essential hypertension].
    Miyazaki N; Shionoiri H; Uneda S; Yasuda G; Gotoh E; Fujishima S; Kaneko Y; Kawahara Y; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):421-8. PubMed ID: 6750186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hypotensive effect of captopril in hypertensive patients is age-related.
    Lijnen P; Fagard R; Groeseneken D; M'Buyamba JR; Staessen J; Amery A
    Methods Find Exp Clin Pharmacol; 1983 Nov; 5(9):655-60. PubMed ID: 6366404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)].
    Di Giulio S; Perez-Ramirez JL; Jamoun P; Grünfeld JP; Meyer P
    Nouv Presse Med; 1981 Apr; 10(19):1551-5. PubMed ID: 6269557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin-angiotensin system in aminoglycoside-induced acute renal failure.
    Luft FC; Aronoff GR; Evan AP; Connors BA; Weinberger MH; Kleit SA
    J Pharmacol Exp Ther; 1982 Feb; 220(2):433-9. PubMed ID: 6276536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term effect of captopril in hypertension with chronic renal failure.
    Gassia JP; Durand D; Ton That H; Degroc F; Suc JM
    Proc Eur Dial Transplant Assoc; 1980; 17():719-24. PubMed ID: 7017704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive activity of captopril (SQ 14,225), an orally active inhibitor of angiotensin converting enzyme in conscious two-kidney perinephritic hypertensive dogs.
    Vollmer RR; Boccagno JA; Steinbacher TE; Horovitz ZP; Murthy VS
    J Pharmacol Exp Ther; 1981 Feb; 216(2):225-31. PubMed ID: 6257882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats.
    Matsumoto K; Nambu K; Fujii T; Takeyama K; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986; 36(1):52-4. PubMed ID: 3006711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril on the development of tolerance to guanethidine.
    Rankin GO; Haas GJ
    Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute renal insufficiency following inhibition of the angiotensin conversion enzyme by various agents].
    Bussien JP; Schaller MD; Nussberger J; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1984 Feb; 114(7):236-9. PubMed ID: 6322293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 17. Captopril in hypertension after renal transplantation.
    Herlitz H; Ahlmén J; Aurell M; Blohmé I; Brynger H; Delin K; Larsson O
    Scand J Urol Nephrol Suppl; 1984; 79():111-4. PubMed ID: 6382584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.
    Curtis JJ; Luke RG; Whelchel JD; Diethelm AG; Jones P; Dustan HP
    N Engl J Med; 1983 Feb; 308(7):377-81. PubMed ID: 6337328
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of captopril in healthy subjects and in patients with cardiovascular diseases.
    Duchin KL; McKinstry DN; Cohen AI; Migdalof BH
    Clin Pharmacokinet; 1988 Apr; 14(4):241-59. PubMed ID: 3292102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of angiotensin-converting enzyme inhibitors in renal failure.
    Sica DA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 10():S13-20. PubMed ID: 1283426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.